The vasodilatory mechanism of nitric oxide and hydrogen sulfide in the human mesenteric artery in patients with colorectal cancer

Hassan,Awat Y.; Maulood,Ismail M.; Salihi,Abbas

doi:10.3892/etm.2021.9646

The vasodilatory mechanism of nitric oxide and hydrogen sulfide in the human mesenteric artery in patients with colorectal cancer

Authors:
- Awat Y. Hassan
- Ismail M. Maulood
- Abbas Salihi
View Affiliations

Affiliations: Department of Biology, College of Science, Salahaddin University‑Erbil, Erbil, Kurdistan Region 44001, Iraq
Published online on: January 15, 2021 https://doi.org/10.3892/etm.2021.9646
Article Number: 214

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Recent studies have focused on the role of gasotransmitters in cancer progression and prevention. Therefore, the current study was designed to explore the vasodilator activity of NO and H₂S in the human mesenteric arteries of patients with colorectal cancer (CRC) via the activation of K⁺ channels. A total of two sets of experiments were established for the current investigation. Blood samples from patients with CRC were obtained to detect serum levels of endocan and malondialdehyde (MDA). The role of K⁺ channels in mediating the vasodilation of the human mesenteric artery in response to sodium nitroprusside (SNP) and sodium disulfide (Na₂S) was assessed. The level of serum endocan was indicated to be decreased in patients with CRC compared with healthy individuals, while the level of serum MDA remained unaltered between groups. The arterial rings pre‑contracted with norepinephrine were first relaxed by the cumulative addition of increasing concentrations of either SNP (30 nM‑30 µM) or (1‑6 mM). Maximal relaxation rates were then calculated at 15 min intervals for 60 min. Pre‑incubation of arterial rings for 20 min with individual K⁺ channel blockers was indicated to significantly reduce SNP‑ and Na₂S‑induced relaxation at different time points. Pre‑treatment of L‑nitro‑arginine methyl ester did not alter vasodilation that was induced by Na₂S. Furthermore, vasodilation of the CRC mesenteric artery was not altered by the synergistic application of SNP and Na₂S, while pre‑incubation of arterial rings with D,L‑propargylglycine significantly enhanced vasodilation induced by SNP. These results indicated that endothelial dysfunction and oxidative stress do not serve roles in the pathogenesis of CRC. The dilatory mechanisms of NO and H₂S in mesenteric arteries of patients with CRC were K⁺ channel‑ and time‑dependent, and the activity of cystathionine γ‑lyase enzyme inhibited the ability of exogenous NO in vasodilation processes.

View Figures

View References

1	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
2	Arafa MA and Farhat KH: Recent diagnostic procedures for colorectal cancer screening: Are they cost-effective? Arab J Gastroenterol. 18:136–139. 2017.PubMed/NCBI View Article : Google Scholar
3	Alhurry AM, Rezaianzadeh A, Rahimikazerooni S, Abd-Zaid Akool M, Bahrami F, Saeedeh Shahidinia S and Pourahmad M: A review of the incidence of colorectal cancer in the Middle East. Ann Colorectal Res. 5(e46292)2017.
4	Khoshnaw N, Mohammed HA and Abdullah DA: Patterns of cancer in Kurdistan-results of eight years cancer registration in sulaymaniyah Province-Kurdistan-Iraq. Asian Pac J Cancer Prev. 16:8525–8531. 2016.PubMed/NCBI View Article : Google Scholar
5	Hamza H and Rasul K: The epidemiology of colorectal cancer in Erbil. Cancer Sci Res. 4:1–7. 2018.
6	Wang R: Two's company, three's a crowd: Can H2S be the third endogenous gaseous transmitter? FASEB J. 16:1792–1798. 2002.PubMed/NCBI View Article : Google Scholar
7	Yang G, Sener A, Ji Y, Pei Y and Pluth MD: Gasotransmitters in biology and medicine: Molecular mechanisms and drug targets. Oxid Med Cell Longev. 2016(4627308)2016.PubMed/NCBI View Article : Google Scholar
8	Moncada S, Palmer RM and Higgs EA: Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol. 38:1709–1715. 1989.PubMed/NCBI View Article : Google Scholar
9	Palmer RM, Rees DD, Ashton DS and Moncada S: L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 153:1251–1256. 1988.PubMed/NCBI View Article : Google Scholar
10	Kabil O and Banerjee R: Enzymology of H2S biogenesis, decay and signaling. Antioxid Redox Signal. 20:770–782. 2014.PubMed/NCBI View Article : Google Scholar
11	Filipovic MR: Persulfidation (S-sulfhydration) and H2S. Handb Exp Pharmacol. 230:29–59. 2015.PubMed/NCBI View Article : Google Scholar
12	Wang R, Cheng Y and Wu L: The role of hydrogen sulfide as an endogenous vasorelaxant factor. In: Signal transduction and the gasotransmitters. Wang R (ed). Humana Press, pp323-332, 2004.
13	Nematollahi S, Nematbakhsh M, Haghjooyjavanmard S, Khazaei M and Salehi M: Inducible nitric oxide synthase modulates angiogenesis in ischemic hindlimb of rat. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 153:125–129. 2009.PubMed/NCBI View Article : Google Scholar
14	Lüscher TF, Boulanger CM, Dohi Y and Yang ZH: Endothelium-derived contracting factors. Hypertension. 19:117–130. 1992.PubMed/NCBI View Article : Google Scholar
15	Chadha PS, Liu L, Rikard-Bell M, Senadheera S, Howitt L, Bertrand RL, Grayson TH, Murphy TV and Sandow SL: Endothelium-dependent vasodilation in human mesenteric artery is primarily mediated by myoendothelial gap junctions intermediate conductance calcium-activated K+ channel and nitric oxide. J Pharmacol Exp Ther. 336:701–708. 2011.PubMed/NCBI View Article : Google Scholar
16	Mustafa AK, Sikka G, Gazi SK, Steppan J, Jung SM, Bhunia AK, Barodka VM, Gazi FK, Barrow RK, Wang R, et al: Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res. 109:1259–1268. 2011.PubMed/NCBI View Article : Google Scholar
17	Szabó C and Papapetropoulos A: Hydrogen sulphide and angiogenesis: Mechanisms and applications. Br J Pharmacol. 164:853–865. 2011.PubMed/NCBI View Article : Google Scholar
18	Tang G, Wu L, Liang W and Wang R: Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol. 68:1757–1764. 2005.PubMed/NCBI View Article : Google Scholar
19	Coletta C, Papapetropoulos A, Erdelyi K, Olah G, Módis K, Panopoulos P, Asimakopoulou A, Gerö D, Sharina I, Martin E and Szabo C: Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc Natl Acad Sci USA. 109:9161–9166. 2012.PubMed/NCBI View Article : Google Scholar
20	Mistry RK and Brewer AC: Redox regulation of gasotransmission in the vascular system: A focus on angiogenesis. Free Radic Biol Med. 108:500–516. 2017.PubMed/NCBI View Article : Google Scholar
21	Hu Q, Wu D, Ma F, Yang S, Tan B, Xin H, Gu X, Chen X, Chen S, Mao Y and Zhu YZ: Novel angiogenic activity and molecular mechanisms of ZYZ-803, a slow-releasing hydrogen sulfide-nitric oxide hybrid molecule. Antioxid Redox Signal. 25:498–514. 2016.PubMed/NCBI View Article : Google Scholar
22	Kashfi K: The dichotomous role of H₂S in cancer cell biology? Deja vu all over again. Biochem Pharmacol. 149:205–223. 2018.PubMed/NCBI View Article : Google Scholar
23	Szabo C: Gasotransmitters in cancer: From pathophysiology to experimental therapy. Nat Rev Drug Discov. 15:185–203. 2016.PubMed/NCBI View Article : Google Scholar
24	Oláh G, Módis K, Törö G, Hellmich MR, Szczesny B and Szabo C: Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation. Biochem Pharmacol. 149:186–204. 2017.PubMed/NCBI View Article : Google Scholar
25	Kather JN, Zöllner FG, Schad LR, Melchers SM, Sinn HP, Marx A, Gaiser T and Weis CA: Identification of a characteristic vascular belt zone in human colorectal cancer. PLoS One. 12(e0171378)2017.PubMed/NCBI View Article : Google Scholar
26	Sonveaux P: Provascular strategy: Targeting functional adaptations of mature blood vessels in tumors to selectively influence the tumor vascular reactivity and improve cancer treatment. Radiother Oncol. 86:300–313. 2008.PubMed/NCBI View Article : Google Scholar
27	Sosa V, Moline T, Somoza R, Paciucci R, Kondoh H and ME LL: Oxidative stress and cancer: An overview. Ageing Res Rev. 12:376–390. 2013.PubMed/NCBI View Article : Google Scholar
28	Gill JG, Piskounova E and Morrison SJ: Cancer, oxidative stress, and metastasis. Cold Spring Harb Symp Quant Biol. 81:163–175. 2016.PubMed/NCBI View Article : Google Scholar
29	Reuter S, Gupta SC, Chaturvedi MM and Aggarwal BB: Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med. 49:1603–1616. 2010.PubMed/NCBI View Article : Google Scholar
30	Perše M: Oxidative stress in the pathogenesis of colorectal cancer: Cause or consequence? Biomed Res Int. 2013(725710)2013.PubMed/NCBI View Article : Google Scholar
31	Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G, Castoria G and Migliaccio A: ROS in cancer therapy: The bright side of the moon. Exp Mol Med. 52:192–203. 2020.PubMed/NCBI View Article : Google Scholar
32	Hsu T, Nguyen-Tran HH and Trojanowska M: Active roles of dysfunctional vascular endothelium in fibrosis and cancer. J Biomed Sci. 26(86)2019.PubMed/NCBI View Article : Google Scholar
33	Orbegozo D, Rahmania L, Irazabal M, Mendoza M, Annoni F, De Backer D, Creteur J and Vincent JL: Endocan as an early biomarker of severity in patients with acute respiratory distress syndrome. Ann Intensive Care. 7(93)2017.PubMed/NCBI View Article : Google Scholar
34	Ohkawa H, Ohishi N and Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95:351–358. 1979.PubMed/NCBI View Article : Google Scholar
35	Furchgott RF and Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:373–376. 1980.PubMed/NCBI View Article : Google Scholar
36	Zuo L, Zhang SM, Hu RL, Zhu HQ, Zhou Q, Gui SY, Wu Q and Wang Y: Correlation between expression and differentiation of endocan in colorectal cancer. World J Gastroenterol. 14:4562–4568. 2008.PubMed/NCBI View Article : Google Scholar
37	Hatfield KJ, Lassalle P, Leiva RA, Lindås R, Wendelboe Ø and Bruserud Ø: Serum levels of endothelium-derived endocan are increased in patients with untreated acute myeloid leukemia. Hematology. 16:351–356. 2011.PubMed/NCBI View Article : Google Scholar
38	Yang J, Yang Q, Yu S and Zhang X: Endocan: A new marker for cancer and a target for cancer therapy. Biomed Rep. 3:279–283. 2015.PubMed/NCBI View Article : Google Scholar
39	Delehedde M, Devenyns L, Maurage CA and Vives RR: Endocan in cancers: A lesson from a circulating dermatan sulfate proteoglycan. Int J Cell Biol. 2013(705027)2013.PubMed/NCBI View Article : Google Scholar
40	Pardo LA and Stuhmer W: The roles of K(+) channels in cancer. Nat Rev Cancer. 14:39–48. 2014.PubMed/NCBI View Article : Google Scholar
41	Gönenç A, Erten D, Aslan S, Akinci M, Simşek B and Torun M: Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. Cell Biol Int. 30:376–380. 2006.PubMed/NCBI View Article : Google Scholar
42	Skrzydlewska E, Sulkowski S, Koda M, Zalewski B, Kanczuga-Koda L and Sulkowska M: Lipid peroxidation and antioxidant status in colorectal cancer. World J Gastroenterol. 11:403–406. 2005.PubMed/NCBI View Article : Google Scholar
43	Subramanyam D, Subbaiah KV, Rajendra W and Lokanatha V: Serum selenium concentration and antioxidant activity in cervical cancer patients before and after treatment. Exp Oncol. 35:97–100. 2013.PubMed/NCBI
44	Plane F, Sampson LJ, Smith JJ and Garland CJ: Relaxation to authentic nitric oxide and SIN-1 in rat isolated mesenteric arteries: Variable role for smooth muscle hyperpolarization. Br J Pharmacol. 133:665–672. 2001.PubMed/NCBI View Article : Google Scholar
45	Chalon S, Tejura B, Moreno H, Urae A, Blaschke TF and Hoffman BB: Role of nitric oxide in isoprenaline and sodium nitroprusside-induced relaxation in human hand veins. Br J Clin Pharmacol. 47:91–98. 1999.PubMed/NCBI View Article : Google Scholar
46	Brayden JE: Functional roles of K_ATP channels in vascular smooth muscle. Clin Exp Pharmacol Physiol. 29:312–316. 2002.PubMed/NCBI View Article : Google Scholar
47	Félétou M: Calcium-activated potassium channels and endothelial dysfunction: Therapeutic options? Br J Pharmacol. 156:545–562. 2009.PubMed/NCBI View Article : Google Scholar
48	Ko EA, Han J, Jung ID and Park WS: Physiological roles of K+ channels in vascular smooth muscle cells. J Smooth Muscle Res. 44:65–81. 2008.PubMed/NCBI View Article : Google Scholar
49	Stankevicius E, Dalsgaard T, Kroigaard C, Beck L, Boedtkjer E, Misfeldt MW, Nielsen G, Schjorring O, Hughes A and Simonsen U: Opening of small and intermediate calcium-activated potassium channels induces relaxation mainly mediated by nitric-oxide release in large arteries and endothelium-derived hyperpolarizing factor in small arteries from rat. J Pharmacol Exp Ther. 339:842–850. 2011.PubMed/NCBI View Article : Google Scholar
50	Jiang J, Thoren P, Caligiuri G, Hansson GK and Pernow J: Enhanced phenylephrine-induced rhythmic activity in the atherosclerotic mouse aorta via an increase in opening of K_Ca channels: Relation to Kv channels and nitric oxide. Br J Pharmacol. 128:637–646. 1999.PubMed/NCBI View Article : Google Scholar
51	Schubert R, Krien U, Wulfsen I, Schiemann D, Lehmann G, Ulfig N, Veh RW, Schwarz JR and Gago H: Nitric oxide donor sodium nitroprusside dilates rat small arteries by activation of inward rectifier potassium channels. Hypertension. 43:891–896. 2004.PubMed/NCBI View Article : Google Scholar
52	Hempelmann RG, Seebeck J, Kruse ML, Ziegler A and Mehdorn HM: Role of potassium channels in the relaxation induced by the nitric oxide (NO) donor DEA/NO in the isolated rat basilar artery. Neurosci Lett. 313:21–24. 2001.PubMed/NCBI View Article : Google Scholar
53	Materazzi S, Zagli G, Nassini R, Bartolini I, Romagnoli S, Chelazzi C, Benemei S, Coratti A, De Gaudio AR and Patacchini R: Vasodilator activity of hydrogen sulfide (H2S) in human mesenteric arteries. Microvasc Res. 109:38–44. 2017.PubMed/NCBI View Article : Google Scholar
54	Zhao W, Zhang J, Lu Y and Wang R: The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J. 20:6008–6016. 2001.PubMed/NCBI View Article : Google Scholar
55	Webb GD, Lim LH, Oh VM, Yeo SB, Cheong YP, Ali MY, El Oakley R, Lee CN, Wong PS, Caleb MG, et al: Contractile and vasorelaxant effects of hydrogen sulfide and its biosynthesis in the human internal mammary artery. J Pharmacol Exp Ther. 324:876–882. 2008.PubMed/NCBI View Article : Google Scholar
56	Zhao W and Wang R: H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol. 283:H474–H480. 2002.PubMed/NCBI View Article : Google Scholar
57	Köhn C, Schleifenbaum J, Szijártó IA, Markó L, Dubrovska G, Huang Y and Gollasch M: Differential effects of cystathionine-γ-lyase-dependent vasodilatory H2S in periadventitial vasoregulation of rat and mouse aortas. PLoS One. 7(e41951)2012.PubMed/NCBI View Article : Google Scholar
58	Teague B, Asiedu S and Moore PK: The smooth muscle relaxant effect of hydrogen sulphide in vitro: Evidence for a physiological role to control intestinal contractility. Br J Pharmacol. 137:139–145. 2002.PubMed/NCBI View Article : Google Scholar
59	Al-Magableh MR and Hart JL: Mechanism of vasorelaxation and role of endogenous hydrogen sulfide production in mouse aorta. Naunyn Schmiedebergs Arch Pharmacol. 383:403–413. 2011.PubMed/NCBI View Article : Google Scholar
60	Doughty JM, Boyle JP and Langton PD: Blockade of chloride channels reveals relaxations of rat small mesenteric arteries to raised potassium. Br J Pharmacol. 132:293–301. 2001.PubMed/NCBI View Article : Google Scholar
61	Salihi A: Activation of inward rectifier potassium channels in high salt impairment of hydrogen sulfide-induced aortic relaxation in rats. Physiol Pharmacol. 19:263–273. 2016.
62	Jackson-Weaver O, Osmond JM, Riddle MA, Naik JS, Gonzalez Bosc LV, Walker BR and Kanagy NL: Hydrogen sulfide dilates rat mesenteric arteries by activating endothelial large-conductance Ca²⁺-activated K⁺ channels and smooth muscle Ca²⁺ sparks. Am J Physiol Heart Circ Physiol. 304:H1446–H1454. 2013.PubMed/NCBI View Article : Google Scholar
63	Liang GH, Xi Q, Leffler CW and Jaggar JH: Hydrogen sulfide activates Ca²⁺ sparks to induce cerebral arteriole dilatation. J Physiol. 590:2709–2720. 2012.PubMed/NCBI View Article : Google Scholar
64	Tang G, Wu L and Wang R: Interaction of hydrogen sulfide with ion channels. Clin Exp Pharmacol Physiol. 37:753–763. 2010.PubMed/NCBI View Article : Google Scholar
65	Whiteman M, Li L, Kostetski I, Chu SH, Siau JL, Bhatia M and Moore PK: Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem Biophys Res Commun. 343:303–310. 2006.PubMed/NCBI View Article : Google Scholar
66	Ali MY, Ping CY, Mok YY, Ling L, Whiteman M, Bhatia M and Moore PK: Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br J Pharmacol. 149:625–634. 2006.PubMed/NCBI View Article : Google Scholar
67	Salihi AB, Shekha MS and Al-Habib OA: Vasodilatory effects of nitric oxide, hydrogen sulfide and sulfur dioxide in rats: Time-dependent interaction study. Prog Biol Sci. 6:19–30. 2016.
68	Filipovic MR, Miljkovic JL, Nauser T, Royzen M, Klos K, Shubina T, Koppenol WH, Lippard SJ and Ivanović-Burmazović I: Chemical characterization of the smallest S-Nitrosothiol, HSNO; cellular cross-talk of H2S and S-nitrosothiols. J Am Chem Soc. 134:12016–12027. 2012.PubMed/NCBI View Article : Google Scholar
69	Cortese-Krott MM, Fernandez BO, Santos JL, Mergia E, Grman M, Nagy P, Kelm M, Butler A and Feelisch M: Nitrosopersulfide (SSNO(-)) accounts for sustained NO bioactivity of S-nitrosothiols following reaction with sulfide. Redox Biol. 2:234–244. 2014.PubMed/NCBI View Article : Google Scholar
70	Ohia SE, Opere CA, Monjok EM, Kouamou G, Leday AM and Njie-Mbye YF: Role of hydrogen sulfide production in inhibitory action of L-cysteine on isolated porcine irides. Curr Eye Res. 35:402–407. 2010.PubMed/NCBI View Article : Google Scholar
71	Monjok EM, Kulkarni KH, Kouamou G, McKoy M, Opere CA, Bongmba ON, Njie YF and Ohia SE: Inhibitory action of hydrogen sulfide on muscarinic receptor-induced contraction of isolated porcine irides. Exp Eye Res. 87:612–616. 2008.PubMed/NCBI View Article : Google Scholar
72	Kashfi K, Chattopadhyay M and Kodela R: NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties. Redox Biol. 6:287–296. 2015.PubMed/NCBI View Article : Google Scholar